WebJan 6, 2024 · PharmaVoice: What’s top of mind for industry execs at JPM? January 6, 2024 / in News / by jrobison. WebMar 30, 2024 · SAN DIEGO, March 30, 2024 (GLOBE NEWSWIRE) -- Dare Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today reported financial results for the year ended December 31,...
Did you know?
WebJul 23, 2024 · We are accelerating innovation in women’s health. At Daré, we believe women’s health is an important therapeutic area that deserves dramatically increased … WebFeb 13, 2024 · SAN DIEGO, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE) today announced the pricing of its previously announced underwritten public offering of 5.0 million shares of its common stock and warrants to purchase up to 3.5 million shares of its common stock.
WebOct 28, 2024 · SAN DIEGO, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, and Strategic Science & Technologies, LLC (SST), a Cambridge, MA based novel topical drug delivery company, today announced a poster presentation at the Sexual Medicine Society of North America … WebAug 9, 2024 · SAN DIEGO, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that the U.S. Food and Drug Administration (FDA)...
WebJan 9, 2024 · Daré Bioscience Announces Publication in Menopause: The Journal of The North American Menopause Society of Data from Phase 1 Trial of DARE-HRT1 that … Web11-50 Employees. Based in San Diego, California. Daré Bioscience is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women’s health. The company’s mission is to …
WebFeb 5, 2024 · SAN DIEGO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that Sabrina Martucci Johnson, its President and Chief Executive Officer, will present at the BIO CEO & Investor Conference on Tuesday, February 11, 2024, at 11:00 a.m. Eastern Time at the …
WebMar 30, 2024 · Daré Bioscience, Inc. filed its 10-K on Mar 30, 2024 for the period ending Dec 31, 2024. ... Press Releases. Security Transactions. Earnings reports. New markets. New products. Corporate strategies. ... Dare Bioscience, Inc. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K) ... simple tech cleaningWebOct 17, 2024 · On October 17, 2024, Dare Bioscience, Inc. ("Dare") issued a press release regarding DARE-HRT1, its investigational combination bio-identical 17?-estradiol and bio-identical... rayfields pharmacy vaWebApr 5, 2024 · April 5, 2024, 7:46 PM · 25 min read. Daré Bioscience, Inc. (NASDAQ: DARE) Q4 2024 Earnings Call Transcript March 30, 2024. Operator: Welcome to the conference call hosted by Daré Bioscience ... rayfield secondary schoolWebFeb 28, 2024 · Scrip Asks…What Does 2024 Hold For Biopharma? Part 7: Clinical Trial Trends (Subscription required) rayfield \u0026 associatesWebMar 30, 2024 · SAN DIEGO, March 30, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reported financial results for the year ended December 31, 2024 and provided a company update. simpletech cape townWebNov 15, 2024 · SAN DIEGO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced it has received a grant from the Bill & Melinda Gates Foundation (the foundation) of $584,986 to support activities related to development of a vaginal thermosetting gel formulation for the … rayfield \\u0026 company mckinneyWebMar 24, 2024 · Daré Bioscience Announces Interim Analysis of Phase 2b RESPOND Study of Sildenafil Cream, 3.6% in Women with Female Sexual Arousal Disorder. … rayfield tree service